IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT06349408 · RECRUITING
Trial details
- NCT number
- NCT06349408
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-10
- Primary completion
- 2026-12-31
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.